A detailed history of Nadler Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Nadler Financial Group, Inc. holds 8,874 shares of ABT stock, worth $1.01 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,874
Previous 8,918 0.49%
Holding current value
$1.01 Million
Previous $1.01 Million 8.98%
% of portfolio
0.11%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $4,432 - $4,947
-44 Reduced 0.49%
8,874 $922,000
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $1,752 - $1,935
16 Added 0.18%
8,918 $1.01 Million
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $475,481 - $582,028
-5,272 Reduced 37.19%
8,902 $979,000
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $28,276 - $33,927
-296 Reduced 2.05%
14,174 $1.37 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $171,023 - $190,556
-1,697 Reduced 10.5%
14,470 $1.58 Million
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $36,225 - $42,639
374 Added 2.37%
16,167 $1.64 Million
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $75,667 - $88,769
-796 Reduced 4.8%
15,793 $1.73 Million
Q3 2022

Oct 31, 2022

SELL
$96.76 - $112.03 $38,413 - $44,475
-397 Reduced 2.34%
16,589 $1.61 Million
Q2 2022

Jul 20, 2022

SELL
$102.07 - $123.37 $306 - $370
-3 Reduced 0.02%
16,986 $1.85 Million
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $97,373 - $118,740
-854 Reduced 4.79%
16,989 $2.01 Million
Q4 2021

Jan 18, 2022

SELL
$115.53 - $141.46 $44,941 - $55,027
-389 Reduced 2.13%
17,843 $2.51 Million
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $41,880 - $46,332
359 Added 2.01%
18,232 $2.15 Million
Q2 2021

Jul 16, 2021

BUY
$105.79 - $124.53 $4,443 - $5,230
42 Added 0.24%
17,873 $2.07 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $27,101 - $31,929
249 Added 1.42%
17,831 $2.14 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $198,240 - $216,024
-1,888 Reduced 9.7%
17,582 $1.93 Million
Q3 2020

Oct 07, 2020

SELL
$91.64 - $111.29 $733 - $890
-8 Reduced 0.04%
19,470 $2.12 Million
Q2 2020

Jul 09, 2020

BUY
$76.57 - $98.0 $236,065 - $302,134
3,083 Added 18.8%
19,478 $1.78 Million
Q1 2020

Apr 09, 2020

SELL
$62.82 - $91.86 $84,241 - $123,184
-1,341 Reduced 7.56%
16,395 $1.29 Million
Q4 2019

Jan 08, 2020

BUY
$78.51 - $87.4 $531,591 - $591,785
6,771 Added 61.75%
17,736 $1.54 Million
Q3 2019

Oct 03, 2019

BUY
$81.84 - $88.74 $27,498 - $29,816
336 Added 3.16%
10,965 $917,000
Q2 2019

Jul 16, 2019

SELL
$72.88 - $85.0 $25,362 - $29,580
-348 Reduced 3.17%
10,629 $894,000
Q1 2019

Apr 04, 2019

SELL
$66.22 - $80.06 $44,367 - $53,640
-670 Reduced 5.75%
10,977 $877,000
Q4 2018

Jan 17, 2019

BUY
$65.56 - $74.27 $3,474 - $3,936
53 Added 0.46%
11,647 $842,000
Q3 2018

Oct 09, 2018

SELL
$60.81 - $73.36 $5,959 - $7,189
-98 Reduced 0.84%
11,594 $851,000
Q2 2018

Jul 10, 2018

BUY
$57.57 - $63.54 $5,814 - $6,417
101 Added 0.87%
11,692 $713,000
Q1 2018

Apr 05, 2018

SELL
$56.27 - $63.62 $30,385 - $34,354
-540 Reduced 4.45%
11,591 $695,000
Q4 2017

Jan 12, 2018

BUY
$53.68 - $57.47 $32,369 - $34,654
603 Added 5.23%
12,131 $692,000
Q3 2017

Oct 11, 2017

BUY
$48.06 - $53.64 $554,035 - $618,361
11,528
11,528 $615,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nadler Financial Group, Inc. Portfolio

Follow Nadler Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.